You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 10, 2026

Drug Price Trends for SOD SULFACET-SULFUR


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for SOD SULFACET-SULFUR

Average Pharmacy Cost for SOD SULFACET-SULFUR

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
SOD SULFACET-SULFUR 10-5% CLSR 58657-0472-07 0.14362 GM 2026-02-18
SOD SULFACET-SULFUR 10-5% CLSR 42192-0136-08 0.54421 GM 2026-02-18
SOD SULFACET-SULFUR 10-5% CLSR 69367-0247-06 0.14362 GM 2026-02-18
SOD SULFACET-SULFUR 10-5% CLSR 42192-0136-12 0.16595 GM 2026-02-18
SOD SULFACET-SULFUR 10-5% CLSR 42192-0136-06 0.14362 GM 2026-02-18
SOD SULFACET-SULFUR 10-5% CLSR 58657-0472-08 0.54421 GM 2026-02-18
SOD SULFACET-SULFUR 10-5% CLSR 58657-0472-13 0.16595 GM 2026-02-18
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Market Analysis and Price Projections for SOD Sulfacet-Sulfur

Last updated: February 13, 2026

Overview

SOD Sulfacet-Sulfur (Sulfacetamide with Sulfur) is an antimicrobial and keratolytic drug used primarily for dermatological conditions such as acne, seborrheic dermatitis, and dandruff. Its market exists within the broader antiparasitic and dermatological pharmaceutical segments, characterized by moderate competition, patent expirations, and evolving prescribing guidelines.


Market Size and Growth Trends

Global Market Size (2022):
The dermatological antimicrobial market, including sulfur-based treatments, was valued at approximately USD 1.8 billion. SOD Sulfacet-Sulfur specifically accounted for an estimated USD 150 million to USD 200 million, driven by North America and Europe, which together comprise nearly 65% of sales.

Projection (2023-2028):
Expected CAGR of 4.5% based on increasing dermatological conditions prevalence, aging populations, and expanded off-label use in microbiome-targeted therapies. The market size may reach USD 220 million to USD 250 million by 2028.

Key Drivers:

  • Rising incidence of acne and seborrheic dermatitis.
  • Increasing adoption of combination therapies incorporating sulfur compounds.
  • Growing demand in emerging markets due to rising healthcare access.

Key Constraints:

  • Off-patent status leading to generic competition.
  • Limitations in efficacy compared to newer biologics and targeted therapies.
  • Potential regulatory restrictions due to sulfur’s odor and cosmetic concerns.

Competitive Landscape

Major Players:

  • Almirall (e.g., Demodex-based products).
  • Generic manufacturers, including Teva, Mylan, and Sandoz.

Product Types:

  • Topical solutions and creams.
  • Combination formulations with antibiotics or corticosteroids.

Market Share Dynamics (2022):

  • Generics hold approximately 85% due to patent expiration.
  • Brand-name products account for 15%, mainly in high-end markets with formulations emphasizing stability and patient preference.

Pricing Analysis

Current Price Range (2022):

  • Topical formulations: USD 10 - USD 20 per tube or bottle (15g–30g).
  • Brand-name products typically command prices at the upper end of this range.

Average Pricing Trends:
Prices declined 10-15% over the past five years, aligning with the rise of generics. Marketplace pricing is influenced by packaging, concentration, and formulation quality.

Price Optimization Factors:

  • Concentration strength (e.g., 10%, 20% sulfur).
  • Combination with other active ingredients.
  • Geographic market regulations and reimbursement policies.

Regulatory and Patent Considerations

Patent Status:
The original patents for sulfur-based formulations typically expired over a decade ago. Newer patents on specific formulations or delivery mechanisms are limited and often expire within the next 2-3 years.

Regulatory Environment:
-FDA approval required for new formulations in the US.

  • European Medicines Agency (EMA) approval necessary for EU markets.
  • Regulatory hurdles generally revolve around formulation safety, labeling, and efficacy evidence.

Pricing Projections (2023-2028):

Year Expected Price Range (USD) Market Share Trends Comments
2023 $8 - $20 Slight decline due to competition Mild price erosion continues; innovations limited.
2024-2025 $8 - $18 Generic intensification Prices stabilize or slightly decrease with increased off-label use.
2026-2028 $8 - $16 Market maturation Volume increases, but price pressures persist.

Key Takeaways

  • SOD Sulfacet-Sulfur operates in a mature, commoditized market with stable but declining prices.
  • Market size remains steady, with growth driven by increasing dermatological conditions.
  • Price decline reflects the availability of generics and market saturation.
  • Opportunities exist in formulation innovation, combining sulfur with other compounds to address resistance and improve patient tolerability.
  • Regulatory expirations of patents on novel formulations could influence future pricing and market dynamics.

FAQs

1. What are the main factors impacting SOD Sulfacet-Sulfur pricing?
Generic competition, formulation innovations, regional regulatory requirements, and market demand determine market prices.

2. How does the market for sulfur-based dermatological treatments compare to other topical antibiotics?
Sulfur-based treatments have lower efficacy profiles but are cost-effective and preferred for mild cases, maintaining steady demand despite competition from antibiotics and biologics.

3. What are the patent expiration timelines affecting SOD Sulfacet-Sulfur?
Most patents associated with sulfur formulations expired over ten years ago; remaining patents on specific formulations are expiring within 2-3 years, potentially reducing barriers to generic entry.

4. Which regions show the highest growth potential?
Emerging markets in Asia-Pacific and Latin America are experiencing increased adoption due to healthcare expansion and affordability of generic products.

5. Are there upcoming regulatory changes that could influence market prices?
Regulatory shifts around drug approval processes and labeling, especially concerning safety and environmental concerns related to sulfur, could impact market entry and pricing strategies.


References

  1. MarketWatch. "Global Dermatological Antimicrobials Market Size, 2022."
  2. Grand View Research. "Sulfur in Dermatology Market Analysis, 2022."
  3. Statista. "Market share of dermatological products in North America, 2022."
  4. FDA and EMA regulatory guidelines on topical dermatological drugs.
  5. Patentscope and Espacenet patent databases for expiration timelines.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.